Approach to male infertility and induction of spermatogenesis

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages 3532-3542

  Anawalt, Bradley D ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CHORIONIC GONADOTROPIN; CLOMIFENE; ESTRADIOL; GONADOTROPIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TESTOSTERONE;

ADULT; ANDROGEN THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ENDOCRINE DISEASE; ESTRADIOL BLOOD LEVEL; GENETIC COUNSELING; GYNECOMASTIA; HEALTH CARE COST; HUMAN; HUMAN CELL; HYPOGONADOTROPIC HYPOGONADISM; KARYOTYPING; MALE; MALE INFERTILITY; MEDICAL EXPERT; MEDICAL HISTORY; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REFERENCE VALUE; SEMEN ANALYSIS; SEXUAL DYSFUNCTION; SPERMATOGENESIS; SPERMATOZOON COUNT; TESTIS DISEASE; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL; WORLD HEALTH ORGANIZATION; Y CHROMOSOME;

ADULT; GENETIC COUNSELING; HUMANS; INFERTILITY, MALE; KARYOTYPING; MALE; SEMEN ANALYSIS; SPERMATOGENESIS;

EID: 84883733320     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2400     Document Type: Article

References (50)

1. Evers JL. Female subfertility. Lancet. 2002;360:151-159.
2. Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod. 2005;20:1144-1147.
3. Jungwirth A, Giwercman A, Tournaye H, et al. 2012 European Association of Urology Guidelines on Male Infertility: the 2012 update. Eur Urol. 2012;62:324-332.
4. Rowland D, McMahon CG, Abdo C, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7:1668-1686.
5. Stanford JB, Dunson DB. Effects of sexual intercourse patterns in time to pregnancy studies. Am J Epidemiol. 2007;165:1088-1095.
6. Sawka AM, Lea J, Alshehri B, et al. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol (Oxf). 2008;68:610-617.
7. Li Y, Lin H, Li Y, Cao J. Association between socio-psycho-behavioral factors and male semen quality: systematic review and metaanalyses. Fertil Steril. 2011;95:116-123.
8. Bari M, Battista N, Pirazzi V, Maccarrone M. The manifold actions of endocannabinoids on female and male reproductive events. Front Biosci. 2011;16:498-516.
9. Waylen AL, Metwally M, Jones GL, Wilkinson AJ, Ledger WL. Effects of cigarette smoking upon clinical outcomes of assisted reproduction: a meta-Analysis.HumReprod Update. 2009;15:31-44.
10. Hofherr SE, Wiktor AE, Kipp BR, Dawson DB, Van Dyke DL. Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience. J Assist Reprod Genet. 2011;28:1091-1098.
11. McLachlan RI, O'Bryan MK. State of the art for genetic testing of infertile men. J Clin Endocrinol Metab. 2010;95:1013-1024.
12. Radicioni AF, De Marco E, Gianfrilli D, et al. Strategies and advantages of early diagnosis in Klinefelter's syndrome. Mol Hum Reprod. 2010;16:434-440.
13. Baazeem A, Belzile E, Ciampi A, et al. Varicocele and male factor infertility treatment: a new meta-Analysis and review of the role of varicocele repair. Eur Urol. 2011;60:796-808.
14. Evers JH, Collins J, Clarke J. Surgery or embolisation for varicoceles in subfertile men. Cochrane Database Syst Rev. 2009;1:CD000479.
15. Kim HH, Goldstein M. Adult varicocele. Curr Opin Urol. 2008; 18:608-612.
16. Male Infertility Best Practice Policy Committee of the American Urological Association; Practice Committee of the American Society for Reproductive Medicine. Report on optimal evaluation of the infertile male. Fertil Steril. 2006;86(5 suppl 1):S202-S209.
17. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31:702-755.
18. Claahsen-van der Grinten HL, Otten BJ, StikkelbroeckMM,Sweep FC, Hermus AR. Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23: 209-220.
19. Sermondade N, Faure C, Fezeu L, Levy R, Czernichow S. Obesity and increased risk for oligozoospermia and azoospermia. Arch Intern Med. 2012;172:440-442.
20. Reis LO, Dias FG. Male fertility, obesity, and bariatric surgery. Reprod Sci. 2012;19:778-785.
21. Hofstra J, Loves S, van Wageningen B, Ruinemans-Koerts J, Jansen I, de Boer H. High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment. Neth J Med. 2008;66:103-109.
22. Teerds KJ, de Rooij DG, Keijer J. Functional relationship between obesity and male reproduction: from humans to animal models. 2011. Hum Reprod Update. 2011;17:667-683.
23. Ohl DA, Quallich SA, Sonksen J, Brackett NL, Lynne CM. Anejaculation and retrograde ejaculation. Urol Clin North Am. 2008; 35:211-220.
24. Jefferys A, Siassakos D, Wardle P. The management of retrograde ejaculation: a systematic review and update. Fertil Steril. 2012;97: 306-312.
25. Behre HM, Nashan D, Nieschlag E. Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int J Androl. 1989;12: 395-403.
26. Sakamoto H, Saito K, Ogawa Y, Yoshida H. Testicular volume measurements using Prader orchidometer versus ultrasonography in patients with infertility. Urology. 2007;69:158-162.
27. Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231-245.
28. Esteves SC, Zini A, Aziz N, Alvarez JG, Sabanegh ES Jr, Agarwal A. Critical appraisal of World Health Organization's new reference values for human semen characteristics and effect on diagnosis and treatment of subfertile men. Urology. 2012;79:16-22.
29. GumusG, Lee J. Alternative paths to parenthood: IVF or child adoption? Econ Inq. 2012;50:802-820.
30. Han TS, Bouloux PM. What is the optimal therapy for young males with hypogonadotropic hypogonadism? Clin Endocrinol (Oxf). 2010;72:731-737.
31. Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90:2595-2602.
32. Liu PY, Baker HW, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab. 2009;94:801-808.
33. WarneDW,Decosterd G, Okada H, Yano Y, Koide N, HowlesCM. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril. 2009;92:594-604.
34. Palermo GD, Neri QV, Takeuchi T, Rosenwaks Z. ICSI: where we have been and where we are going. Semin Reprod Med. 2009;27: 191-201.
35. Sunderam S, Chang J, Flowers L, et al; Centers for Disease Control and Prevention (CDC). Assisted reproductive technology surveillance- United States, 2006.MMWRSurveillSumm. 2009;58:1-25.
36. Fullerton G, Hamilton M, Maheshwari A. Should non-mosaic Klinefelter syndrome men be labelled as infertile in 2009? Hum Reprod. 2010;25:588-597.
37. Davies MJ,MooreVM,Willson KJ, et al. Reproductive technologies and the risk of birth defects. N Engl J Med. 2012;366:1803-1813.
38. Ko EY, Siddiqi K, Brannigan RE, Sabanegh ES Jr. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol. 2012;187:973-978.
39. Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA, Handelsman DJ. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab. 2005;90:5928-5936.
40. Grigorova M, Punab M, Zilaitiene B, et al. Genetically determined dosage of follicle-stimulating hormone (FSH) affects male reproductive parameters. J Clin Endocrinol Metab. 2011;96:E1534-E1541.
41. Tüttelmann F, Laan M, Grigorova M, Punab M, Sober S, Gromoll J. Combined effects of the variants FSHB -211GT and FSHR 2039AG on male reproductive parameters. J Clin Endocrinol Metab. 2012;97:3639-3647.
42. Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC, Foresta C. Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone-subunit promoter. Fertil Steril. 2011;96:1344-1349.
43. Selice R, Garolla A, Pengo M, Caretta N, Ferlin A, Foresta C. The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. Int J Androl. 2011;34:306-312.
44. Attia AM, Al-Inany HG, Farquhar C, Proctor M. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev. 2007;4:CD005071.
45. Roth MY, Amory JK, Page ST. Treatment of male infertility secondary to morbid obesity. Nat Clin Pract Endocrinol Metab. 2008; 4:415-419.
46. Menon DK. Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin. Fertil Steril. 2003;79(suppl 3):1659-1661.
47. de la Torre Abril L, Ramada Benlloch F, Sanchez Ballester F, et al. Management of male sterility in patients taking anabolic steroids [in Spanish]. Arch Esp Urol. 2005;58:241-244.
48. Nachtigall LB, Boepple PA, Pralong FP, CrowleyWFJr. Adult-onset idiopathic hypogonadotropic hypogonadism-A treatable form of male infertility. N Engl J Med. 1997;336:410-415.
49. Dwyer AA, Hayes FH, Plummer L, Pitteloud N, CrowleyWFJr. The long-term clinical follow-up and natural history of men with adultonset idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2010;95:4235-4243.
50. Matsumoto AM, Karpas AE, Bremner WJ. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle- stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. J Clin Endocrinol Metab. 1986;62:1184-1192.